BMJ Group Logo

BMJ Group and University of Cambridge Professional and Continuing Education partner to strengthen data literacy in healthcare

27 April 2026—BMJ Group and the University of Cambridge Professional and Continuing Education (PACE) have partnered to deliver postgraduate-level healthcare data science courses. The courses support clinicians to analyse health data and strengthen evidence based decision making. The collaboration will see selected University of Cambridge courses hosted on BMJ Learning, ...

Should doctors comment on a president’s mental health?

As the oldest person elected president of the United States, Donald Trump has long faced questions about his health. But is it appropriate for doctors to comment publicly on a president’s mental health? In an opinion article published by The BMJ today, David Nicholl and Trisha Greenhalgh examine the ethical ...

2026-04-21T15:56:17+01:0023 April 2026|Press release, The BMJ|

UK Women’s Health Strategy signals shift from listening to action, with women shaping care design

The UK’s renewed Women’s Health Strategy, announced by the Department of Health and Social Care, NHS England and Wes Streeting, signals a shift from listening to action, with women’s voices more directly shaping how care is designed and improved. There is a clear focus on faster diagnosis, more joined-up ...

2026-04-16T12:11:18+01:0016 April 2026|Collection, Corporate announcement, Partnership, The BMJ|

For women with primary progressive multiple sclerosis, could Roche’s best selling drug be doing more harm than good?

Investigation explores how an $80,000 a year drug was approved for primary progressive form of MS despite concerns over its safety and effectiveness  The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche’s top-selling drug ocrelizumab (Ocrevus) for treating primary progressive multiple sclerosis ...

2026-04-15T16:03:41+01:0016 April 2026|Press release, The BMJ|
Go to Top